This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →
Consolidated Sep 2026 quarter: revenue Rs 306.03 lakh, profit after tax Rs 8.25 lakh
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 19.5 pts less than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
For the consolidated quarter ended September 30, 2026, revenue from operations was Rs 306.03 lakh and profit after tax Rs 8.25 lakh; no September 2025 consolidated comparison was provided. Consolidated half-year revenue was Rs 1,231.72 lakh, profit after tax Rs 102.41 lakh and operating cash flow Rs 7.57 lakh. The board approved the results, and the limited review was unmodified. Prior figures were restated for comparability.
Low consolidated profit and the subsidiary's Rs 8.01 lakh loss may weigh on sentiment, though positive cash flow and low borrowings offer support.
| Q2 FY27 | Q2 FY26 | Change | |
|---|---|---|---|
| Revenue | ₹3.06 Cr | ₹7.19 Cr | −57.5% |
| Operating profit | −₹0.02 Cr | ₹0.60 Cr | −103.0% |
| Profit after tax | ₹0.16 Cr | ₹0.54 Cr | −70.2% |
| EBITDA margin | 0.1% | 8.5% | −8.4 pp |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.